Reports
Sale
Global Life Science Tools Market Size, Analysis, Forecast: By Technology: Genomic Technology, Proteomics Technology, Cell Biology Technology, Other Analytical and Sample Preparation Technology, Lab Supplies and Technologies, Others; By Product Type; By End User; Regional Analysis; Grants Analysis; Supplier Landscape; 2024-2032
Global Life Science Tools Market Outlook
The global life science tools market size was valued at USD 120.12 billion in 2023, driven by the increased research and development activities about life science across the globe. The market size is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032 to achieve a value of USD 271.86 billion by 2032.
Life Science Tools: Introduction
Life sciences is the study of living organisms and life processes. Biotechnology is the most prominent component of the life sciences. It is a toolbox that leverages the basic understanding of natural sciences to create effective solutions for various world problems. Biotechnology is used to grow food to feed families and to make medicines and vaccines to fight diseases. Researchers and scientists are turning to biotechnology to find alternatives to fossil-based fuels for a cleaner, healthier planet.
The major life science tools include microscopy instruments, molecular analysis instruments, spectroscopy instruments, chromatography instruments and flow cytometry instruments. Other instruments include mass spectrometry instruments, biotechnology instruments, imaging systems, automated liquid handling systems, clinical diagnostics instruments, and laboratory automation systems, among others.
Global Life Science Tools Market Analysis
The growth of gene and cell therapies and their rising demand is anticipated to propel the market for life science tools. Various companies have started investing more funds and efforts on accelerating their research and development for efficient gene therapies. The therapies that can potentially address the cause of disease at the genetic level, further elevating the global life science tools market growth in response to the growing demand for effective disease treatment solutions.
Gene treatments are predicted to have a positive outlook in the coming years owing to an increase in the number of FDA-approved products. Furthermore, it is anticipated that improvements in recombinant DNA technology would increase the number of active clinical trials for gene therapy.
The market has significantly benefited from developments in targeted therapy due to a better understanding of how drugs interact with patients' genetic makeup. The life science segment is currently making use of cutting-edge developments like predictive analytics to improve the production of biological treatments to keep up with the market's rising demand further propelling the global life science tools market development.
Additionally, the FDA's clearance of monoclonal antibodies for use in cancer therapy and diagnostics is expanding the uses of biologics, which is projected to further enhance the market size. The growing synergy between academics and the life sciences sector is also fueling the market growth.
Global Life Science Tools Market Segmentations
Market Breakup by Technology
- Genomic Technology
- Proteomics Technology
- Cell Biology Technology
- Other Analytical and Sample Preparation Technology
- Lab Supplies and Technologies
- Others
Market Breakup by Product Type
- Cell Culture Systems and 3D Cell Culture
- Instruments
- Consumables
- Cell and Tissue Culture Services
- Liquid Chromatography
- Instruments
- Consumables
- Services
- Mass Spectrometry
- Instruments
- Consumables
- Services
- Flow Cytometry
- Instruments
- Consumables
- Services
- Cloning and Genome Engineering
- Kits, Reagents, and Consumables
- Services
- Microscopy and Electron Microscopy
- Instruments
- Consumables
- Services
- Next Generation Sequencing
- Instruments
- Consumables
- Services
- PCR and qPCR
- Instruments
- Consumables
- Services
- Nucleic Acid Preparation
- Instruments
- Consumables
- Services
- Nucleic Acid Microarray
- Instruments
- Consumables
- Services
- Sanger Sequencing
- Instruments
- Consumables
- Services
- Transfection Devices and Gene Delivery Technologies
- Equipment
- Reagents
- NMR
- Instruments
- Consumables
- Services
- Other Separation Technologies
- Instruments
- Consumables
- Services
- Other Products and Services
- Antibodies
- General Supplies
- Others
Market Breakup by End User
- Government and Academic
- Biopharmaceutical Company
- Healthcare
- Industrial Applications
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Life Science Tools Market Overview
The market for life science tools is expanding significantly as a result of ongoing developments made by the industry's leading manufacturers in the fields of sequencing, MS, chromatography, and NMR, among other goods. The rising investments made by governments and pharmaceutical corporations in the creation of cutting-edge therapies are also aiding the growth of the market. With the rising prevalence of diseases like cancer, renal and thyroid disorders, and diabetes, there is an increased desire for novel medicines and treatments, which is projected to add further value the global life science tools market share.
The rapid advancement of gene treatments and immunotherapies, which have shown promising results in curing diseases that were previously incurable, have been fuelling the growth of the market.
As pharmaceutical companies continue to invest more and more intensively in their development and allocate a larger portion of their research and development budget to biologics, biopharmaceuticals made from biological sources, such as living cells, will continue to gain prominence in the forecast period.
The growth of the market is also anticipated to be propelled by the increased collaboration between businesses, non-profit organisations, governments, and academic institutions in the development of innovative therapies and technologies.
Life Science Tools Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- QIAGEN N.V.
- Merck KGaA
- Shimadzu Corporation
- Hitachi, Ltd.
- Bruker Corporation
- Oxford Instruments plc
- Zeiss International
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Product Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Life Science Tools Market Overview
3.1 Global Life Science Tools Market Historical Value (2017-2023)
3.2 Global Life Science Tools Market Forecast Value (2024-2032)
4 Global Life Science Tools Market Landscape
4.1 Global Life Science Tools Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Life Science Tools Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Products
5 Global Life Science Tools Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Life Science Tools Market Segmentation
6.1 Global Life Science Tools Market by Technology
6.1.1 Market Overview
6.1.2 Genomic Technology
6.1.3 Proteomics Technology
6.1.4 Cell Biology Technology
6.1.5 Other Analytical and Sample Preparation Technology
6.1.6 Lab Supplies and Technologies
6.1.7 Others
6.2 Global Life Science Tools Market by Product Type
6.2.1 Cell Culture Systems and 3D Cell Culture
6.2.1.1 Instruments
6.2.1.2 Consumables
6.2.1.3 Cell and Tissue Culture Services
6.2.2 Liquid Chromatography
6.2.2.1 Instruments
6.2.2.2 Consumables
6.2.2.3 Services
6.2.3 Mass Spectrometry
6.2.3.1 Instruments
6.2.3.2 Consumables
6.2.3.3 Services
6.2.4 Flow Cytometry
6.2.4.1 Instruments
6.2.4.2 Consumables
6.2.4.3 Services
6.2.5 Cloning and Genome Engineering
6.2.5.1 Kits, Reagents, and Consumables
6.2.5.2 Services
6.2.6 Microscopy and Electron Microscopy
6.2.6.1 Instruments
6.2.6.2 Consumables
6.2.6.3 Services
6.2.7 Next Generation Sequencing
6.2.7.1 Instruments
6.2.7.2 Consumables
6.2.7.3 Services
6.2.8 PCR & qPCR
6.2.8.1 Instruments
6.2.8.2 Consumables
6.2.8.3 Services
6.2.9 Nucleic Acid Preparation
6.2.9.1 Instruments
6.2.9.2 Consumables
6.2.9.3 Services
6.2.10 Nucleic Acid Microarray
6.2.10.1 Instruments
6.2.10.2 Consumables
6.2.10.3 Services
6.2.11 Sanger Sequencing
6.2.11.1 Instruments
6.2.11.2 Consumables
6.2.11.3 Services
6.2.12 Transfection Devices and Gene Delivery Technologies
6.2.12.1 Equipment
6.2.12.2 Reagents
6.2.13 NMR
6.2.13.1 Instruments
6.2.13.2 Consumables
6.2.13.3 Services
6.2.14 Other Separation Technologies
6.2.14.1 Instruments
6.2.14.2 Consumables
6.2.14.3 Services
6.2.15 Other Products and Services
6.2.15.1 Antibodies
6.2.15.2 General Supplies
6.2.15.3 Others
6.3 Global Life Science Tools Market by End User
6.3.1 Market Overview
6.3.2 Government and Academic
6.3.3 Biopharmaceutical Company
6.3.4 Healthcare
6.3.5 Industrial Applications
6.3.6 Others
6.4 Global Life Science Tools Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Life Science Tools Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Life Science Tools Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Life Science Tools Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Life Science Tools Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Life Science Tools Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Agilent Technologies, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Becton, Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 F. Hoffmann-La Roche Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Bio-Rad Laboratories, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Danaher Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Illumina, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Thermo Fisher Scientific, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 QIAGEN N.V.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Merck KGaA
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Shimadzu Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Hitachi, Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Bruker Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Oxford Instruments plc
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 Zeiss International
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
18 Global Life Science Tools Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 120.12 billion in 2023, driven by the increased research and development activities.
The market is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, likely to reach a market value of USD 271.86 billion by 2032.
The factors which are contributing to the market growth include the rapidly developing healthcare sector and the increasing investments by governments and pharmaceutical corporations in the development of cutting-edge therapies, among others.
The development of targeted therapy due to a better understanding of how drugs interact with patients' genetic makeup is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different life science tools present in the market are cell culture systems and 3d cell culture, liquid chromatography, mass spectrometry, flow cytometry, cloning and genome engineering, microscopy and electron microscopy, next generation sequencing, PCR and qPCR, nucleic acid preparation, nucleic acid microarray, sanger sequencing, transfection devices and gene delivery technologies, NMR, other separation technologies, products and services, among others.
The technologies used in life science tools are genomic technology, proteomics technology, cell biology technology, other analytical and sample preparation technology, lab supplies and technologies, among others.
The end users of life science tools are government and academic, biopharmaceutical company, healthcare, and industrial applications, among others.
Key players involved in the market are Agilent Technologies, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker Corporation, Oxford Instruments plc, and Zeiss International.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER